The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Unexpected Effect of Proton Pump Inhibitors: Elevation of the Cardiovascular Risk Factor Asymmetric Dimethylarginine
Open accessAbstract
Background—: Proton pump inhibitors (PPIs) are gastric acid–suppressing agents widely prescribed for the treatment of gastroesophageal reflux disease. Recently, several studies in patients with acute coronary syndrome have raised the concern that use of PPIs in these patients may increase their risk of major adverse cardiovascular events. The mechanism of this possible adverse effect is not known. Whether the general population might also be at risk has not been addressed. Methods and Results—: Plasma asymmetrical dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase. Elevated plasma ADMA is associated with increased risk for cardiovascular disease, likely because of its attenuation of the vasoprotective effects of endothelial nitric oxide synthase. We find that PPIs elevate plasma ADMA levels and reduce nitric oxide levels and endothelium-dependent vasodilation in a murine model and ex vivo human tissues. PPIs increase ADMA because they bind to and inhibit dimethylarginine dimethylaminohydrolase, the enzyme that degrades ADMA. Conclusions—: We present a plausible biological mechanism to explain the association of PPIs with increased major adverse cardiovascular events in patients with unstable coronary syndromes. Of concern, this adverse mechanism is also likely to extend to the general population using PPIs. This finding compels additional clinical investigations and pharmacovigilance directed toward understanding the cardiovascular risk associated with the use of the PPIs in the general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
Schächinger, V., Britten, M. B., & Zeiher, A. M. (2000) · Circulation · doi:10.1161/01.cir.101.16.1899 · Cited by 2,585
HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell Line
Ades, E. W., Candal, F. J., Swerlick, R. A., George, V. G., Summers, S., Bosse, D. C., & Lawley, T. J. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12613748 · Cited by 1,265
Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087
Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
Gilard, M., Arnaud, B., Cornily, J.-C., Le Gal, G., Lacut, K., Le Calvez, G., Mansourati, J., Mottier, D., Abgrall, J.-F., & Boschat, J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.064 · Cited by 1,015
Ho, P. M. (2009) · JAMA · doi:10.1001/jama.2009.261 · Cited by 1,007
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
Juurlink, D. N., Gomes, T., Ko, D. T., Szmitko, P. E., Austin, P. C., Tu, J. V., Henry, D. A., Kopp, A., & Mamdani, M. M. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.082001 · Cited by 766
Homocysteine Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine
Stühlinger, M. C., Tsao, P. S., Her, J.-H., Kimoto, M., Balint, R. F., & Cooke, J. P. (2001) · Circulation · doi:10.1161/hc4601.098514 · Cited by 662
Self-citationLi, X.-Q., Andersson, T. B., Ahlström, M., & Weidolf, L. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.8.821 · Cited by 644
Böger, R. H., Sydow, K., Borlak, J., Thum, T., Lenzen, H., Schubert, B., Tsikas, D., & Bode-Böger, S. M. (2000) · Circulation Research · doi:10.1161/01.res.87.2.99 · Cited by 479
Disruption of methylarginine metabolism impairs vascular homeostasis
Leiper, J., Nandi, M., Torondel, B., Murray-Rust, J., Malaki, M., O'Hara, B., Rossiter, S., Anthony, S., Madhani, M., Selwood, D., et al. (2007) · Nature Medicine · doi:10.1038/nm1543 · Cited by 402
Self-citationAsymmetrical Dimethylarginine: The Über Marker?
Cooke, J. P. (2004) · Circulation · doi:10.1161/01.cir.0000126823.07732.d5 · Cited by 396
Self-citationSchnabel, R., Blankenberg, S., Lubos, E., Lackner, K. J., Rupprecht, H. J., Espinola-Klein, C., Jachmann, N., Post, F., Peetz, D., Bickel, C., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000181286.44222.61 · Cited by 378
Reimer, C., Søndergaard, B., Hilsted, L., & Bytzer, P. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.058 · Cited by 356
Abbasi, F., Asagmi, T., Cooke, J. P., Lamendola, C., McLaughlin, T., Reaven, G. M., Stuehlinger, M., & Tsao, P. S. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02063-x · Cited by 354
Self-citationBöger, R. H., Sullivan, L. M., Schwedhelm, E., Wang, T. J., Maas, R., Benjamin, E. J., Schulze, F., Xanthakis, V., Benndorf, R. A., & Vasan, R. S. (2009) · Circulation · doi:10.1161/circulationaha.108.838268 · Cited by 351
Palm, F., Onozato, M. L., Luo, Z., & Wilcox, C. S. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00998.2007 · Cited by 336
Zoccali, C., Benedetto, F. A., Maas, R., Mallamaci, F., Tripepi, G., Salvatore Malatino, L., & Bo[Combining Diaeresis]ger, R. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v132490 · Cited by 319
Stedman, C. A. M., & Barclay, M. L. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00788.x · Cited by 317
Leiper, J., Murray-Rust, J., McDonald, N., & Vallance, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212269799 · Cited by 288
Self-citationCharlot, M., Ahlehoff, O., Norgaard, M. L., Jørgensen, C. H., Sørensen, R., Abildstrøm, S. Z., Hansen, P. R., Madsen, J. K., Køber, L., Torp-Pedersen, C., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-6-201009210-00005 · Cited by 264
The gastric HK-ATPase: structure, function, and inhibition
Shin, J. M., Munson, K., Vagin, O., & Sachs, G. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-008-0495-4 · Cited by 263
Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay
Schulze, F., Wesemann, R., Schwedhelm, E., Sydow, K., Albsmeier, J., Cooke, J. P., & Böger, R. H. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.257 · Cited by 251
Self-citationChen, J.-W., Hsu, N.-W., Wu, T.-C., Lin, S.-J., & Chang, M.-S. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02664-4 · Cited by 230
Murray‐Rust, J., LEIPER, J. M., McAlister, M. S. B., Phelan, J. P., Tilley, S. J., MARIA, J. S., Vallance, P. J., & McDonald, N. Q. (2001) · Nature Structural Biology · doi:10.1038/90387 · Cited by 217
Self-citationZoccali, C., Mallamaci, F., Maas, R., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Böger, R., & on behalf of The Creed Investigators (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00437.x · Cited by 214
Charlot, M., Grove, E. L., Hansen, P. R., Olesen, J. B., Ahlehoff, O., Selmer, C., Lindhardsen, J., Madsen, J. K., Kober, L., Torp-Pedersen, C., et al. (2011) · BMJ · doi:10.1136/bmj.d2690 · Cited by 199
Yao, S. K., Ober, J. C., Krishnaswami, A., Ferguson, J. J., Anderson, H. V., Golino, P., Buja, L. M., & Willerson, J. T. (1992) · Circulation · doi:10.1161/01.cir.86.4.1302 · Cited by 198
Goodman, S. G., Clare, R., Pieper, K. S., Nicolau, J. C., Storey, R. F., Cantor, W. J., Mahaffey, K. W., Angiolillo, D. J., Husted, S., Cannon, C. P., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.032912 · Cited by 194
Proton pump inhibitors and acute interstitial nephritis: Report and analysis of 15 cases
Simpson, I. J., Marshall, M. R., Pilmore, H., MANLEY, P., Williams, L. C., THEIN, H., & Voss, D. (2006) · Nephrology · doi:10.1111/j.1440-1797.2006.00651.x · Cited by 155
Cytoprotective effects of nitric oxide.
Cooke, J. P., & Tsao, P. S. (1993) · Circulation · doi:10.1161/01.cir.88.5.2451 · Cited by 152
Self-citationWelage, L. S., & Berardi, R. R. (2000) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31036-1 · Cited by 149
Mittermayer, F., Krzyżanowska, K., Exner, M., Mlekusch, W., Amighi, J., Sabeti, S., Minar, E., Müller, M. M., Wolzt, M., & Schillinger, M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000242801.38419.48 · Cited by 144
Leong, T., Zylberstein, D. E., Graham, I. M., Lissner, L., Ward, D., Fogarty, J., Bengtsson, C., Björkelund, C., & Thelle, D. S. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.156596 · Cited by 142
Maggio, M. G., Corsonello, A., Ceda, G. P., Cattabiani, C., Lauretani, F., Buttò, V., Ferrucci, L., Bandinelli, S., Abbatecola, A. M., Spazzafumo, L., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.2851 · Cited by 124
Copeland, R. A., Basavapathruni, A., Moyer, M. P., & Scott, M. P. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.05.029 · Cited by 119
Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population
Wanby, P., Teerlink, T., Brudin, L. H., Brattström, L. E., Nilsson, I., Palmqvist, P., & Carlsson, M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.06.033 · Cited by 107
Kwok, C. S., Jeevanantham, V., Dawn, B., & Loke, Y. K. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.085 · Cited by 106
Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease
Wang, J., Sim, A. S., Wang, X. L., Salonikas, C., Naidoo, D., & Wilcken, D. E. L. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.05.002 · Cited by 96
Tsui, J. C. S., Souza, D. S. R., Filbey, D., Karlsson, M. G., & Dashwood, M. R. (2002) · Journal of Vascular Surgery · doi:10.1067/mva.2002.121072 · Cited by 85
Ding, H., Wu, B., Wang, H., Lu, Z., Yan, J., Wang, X., Shaffer, J. R., Hui, R., & Wang, D. W. (2010) · Circulation Research · doi:10.1161/circresaha.109.215616 · Cited by 84
Altınova, A. E., Arslan, M., Dinçel, A. S., Aktürk, M., Altan, N., & Törüner, F. B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2643 · Cited by 80
Lu, T., Chung, M., Lin, M., Hsu, C., & Lin, S. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.06.120 · Cited by 79
Asymmetric Dimethylarginine and Clinical Outcomes in Chronic Kidney Disease
Lu, T., Chung, M., Lin, C., Hsu, C., & Lin, S. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08490910 · Cited by 76
Abhary, S., Burdon, K. P., Kuot, A., Javadiyan, S., Whiting, M. J., Kasmeridis, N., Petrovsky, N., & Craig, J. E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009462 · Cited by 71
Frey, D., Braun, O., Briand, C., Vašák, M., & Grütter, M. G. (2006) · Structure · doi:10.1016/j.str.2006.03.006 · Cited by 67
Wilson, A., Shin, D. S., Weatherby, C., Harada, R. K., Ng, M. K., Nair, N., Kielstein, J. T., & Cooke, J. P. (2010) · Vascular Medicine · doi:10.1177/1358863x10364552 · Cited by 67
Self-citationShin, J. M., Homerin, M., Domagala, F., Ficheux, H., & Sachs, G. M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.11.030 · Cited by 60
Lin, H., & Fast, W. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707231200 · Cited by 55
Proton pump inhibitor side effects and drug interactions: Much ado about nothing?
Madanick, R. D. (2011) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77a.10087 · Cited by 53
Kim, Y. J., Lee, J. S., Hong, K. S., Chung, J. W., Kim, J. H., & Hahm, K. B. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0033 · Cited by 50
Self-citationDDAH gene and cardiovascular risk
Valkonen, V.-P., Tuomainen, T., & Laaksonen, R. (2005) · Vascular Medicine · doi:10.1191/1358863x05vm600oa · Cited by 48
Özgürtaş, T., Öktenli, Ç., Dede, M., Tapan, S., Kenar, L., Sanisoğlu, S. Y., Yeşilova, Z., Yenen, M. C., Erbil, M. K., & Başer, İ. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.054 · Cited by 39
A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine
Arı, H., Arı, S., Erdoğan, E., Tiryakioğlu, O., Üstündağ, Y., Huysal, K., Koca, V., & Bozat, T. (2010) · Heart and Vessels · doi:10.1007/s00380-009-1158-x · Cited by 38
Nandi, M., Kelly, P. D., Torondel, B., Wang, Z., Starr, A., Ma, Y., Cunningham, P., Stidwill, R. P., & LEIPER, J. M. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300232 · Cited by 34
Self-citationProton-pump inhibitors in acid-related diseases
Berardi, R. R., & Welage, L. S. (1998) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/55.21.2289 · Cited by 32
Sakurada, M., Shichiri, M., Imamura, M., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114207 · Cited by 27
Adenoviral-mediated overexpression of DDAH improves vascular tone regulation
Torondel, B., Nandi, M., Kelly, P. D., Wójciak‐Stothard, B., Fleming, I., & LEIPER, J. M. (2010) · Vascular Medicine · doi:10.1177/1358863x09360264 · Cited by 23
Self-citationGhebremariam, Y. T., Erlanson, D. A., Yamada, K., & Cooke, J. P. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112441521 · Cited by 21
Self-citation
Cited by
Endothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
Freedberg, D. E., Kim, L. S., & Yang, Y.-X. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.031 · Cited by 891
Strategies to increase nitric oxide signalling in cardiovascular disease
Lundberg, J. O., Gladwin, M. T., & Weitzberg, E. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4623 · Cited by 576
Moayyedi, P., Eikelboom, J. W., Bosch, J., Connolly, S. J., Dyal, L., Shestakovska, O., Leong, D., Anand, S. S., Störk, S., Branch, K. R. H., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.056 · Cited by 483
Complications of Proton Pump Inhibitor Therapy
Vaezi, M. F., Yang, Y.-X., & Howden, C. W. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.047 · Cited by 482
Metadata
- Authors
- Ghebremariam, Y. T., LePendu, P., Lee, J. C., Erlanson, D. A., Slaviero, A., Shah, N. H., Leiper, J., & Cooke, J. P.
- Venue
- Circulation
- Published
- 2013-08-20
- Volume
- 128
- Issue
- 8
- Pages
- 845-853
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2302382872
- Cited by
- 255
- References
- 59
- FWCI
- 11.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.